| Literature DB >> 33263756 |
Elizabeth M Anderson1, Caroline Diorio2,3, Eileen C Goodwin1, Kevin O McNerney2,3, Madison E Weirick1, Sigrid Gouma1, Marcus J Bolton1, Claudia P Arevalo1, Julie Chase2,4, Philip Hicks1,5, Tomaz B Manzoni1, Amy E Baxter6,7, Kurt P Andrea6,7, Chakkapong Burudpakdee2, Jessica H Lee2, Laura A Vella6,7,8, Sarah E Henrickson9, Rebecca M Harris10, E John Wherry6,7, Paul Bates1,11, Hamid Bassiri2,8, Edward M Behrens2,4, David T Teachey2,3, Scott E Hensley1.
Abstract
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.Entities:
Keywords: COVID-19; SARS-COV-2; antibodies; multisystem inflammatory syndrome in children (MIS-C); pediatric
Mesh:
Substances:
Year: 2021 PMID: 33263756 PMCID: PMC7799010 DOI: 10.1093/jpids/piaa161
Source DB: PubMed Journal: J Pediatric Infect Dis Soc ISSN: 2048-7193 Impact factor: 3.164